Y 20024
| Code | Size | Price |
|---|
| TAR-T35225-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Y 20024 is a biochemical.
CAS:
124842-93-9
Formula:
C19H30ClN3O4S
Molecular Weight:
431.98
Purity:
0.98
SMILES:
Cl.CCCCN1CCC[C@@H]1CNC(=O)c1cc(cc2C[C@@H](C)Oc12)S(N)(=O)=O
References
Fukuda T, Morimoto Y, Morimoto T, Shoji H, Murakami S, Tahara T, Setoguchi M. [Neuroleptic properties of Y-20024, a new benzofurancarboxamide derivative]. Nihon Yakurigaku Zasshi. 1989 Nov;94(5):269-80. Japanese. PubMed PMID: 2575566.
Yamada I, Mizuta H, Ogawa K, Tahara T. Comparative pharmacokinetics of sulpiride and N-[(1-butyl-2-pyrrolidinyl)methyl]-2-methyl-5-sulfamoyl-2,3- dihydrobenzofuran-7-carboxamide hydrochloride, a new lipophilic substituted benzamide in rats. Chem Pharm Bull (Tokyo). 1990 Sep;38(9):2552-5. PubMed PMID: 1981028.